Encorium Group, Inc. (ENCO) Completes $1.6 Million Private Placement of Common Stock and Executes Warrant Exchange Agreement
10/19/2009 9:27:06 AM
More...
|
Encorium Group, Inc. (ENCO) Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial Win; Company Successful with its Strategic Focus on Vaccines and Oncology Trials
9/9/2009 8:43:24 AM
More...
|
Encorium Group, Inc. (ENCO) Completes Sale of its U.S. Business to Pierrel Research USA
7/17/2009 8:37:55 AM
More...
|
Encorium Group, Inc. (ENCO) Updates Expected Timeframe with Respect to the Sale of its U.S. Business
7/1/2009 10:09:33 AM
More...
|
Encorium Group, Inc. (ENCO) Reports First Quarter 2009 Financial Results
5/20/2009 10:49:46 AM
More...
|
Encorium Group, Inc. (ENCO) Provides Update to LOI with Respect to the Sale of its U.S. Business
5/19/2009 11:00:18 AM
More...
|
Encorium Group, Inc. (ENCO) Enters into Non-Binding Letters of Intent
5/12/2009 8:44:08 AM
More...
|
Encorium Group, Inc. (ENCO) Reports Fourth Quarter and Full Year 2008 Financial Results
4/28/2009 11:49:50 AM
More...
|
Encorium Group, Inc. (ENCO) Postpones Filing of 10-K as it Evaluates Goodwill Impairment Charge
3/31/2009 11:34:05 PM
More...
|
Encorium Group, Inc. (ENCO) Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company
1/28/2009 8:59:31 AM
More...
|
|